FARRAGUT PARTNERS LLP

Lobbying for HERON THERAPEUTICS, INC. · â€‹Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation

Medicare/Medicaid

Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.